SCHEMBL4661571

SCHEMBL4661571

COc1ccccc1[C@@H](c1cccc2ccccc12)[C@@](C#N)(Cc1cccnc1)C(=O)O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 1/20 0.45
IDO1 P14902 2/20 0.41
ESR1 P03372 1/20 0.40
ESR2 Q92731 1/20 0.40
MAPT P10636 2/20 0.40
CYP1A2 P05177 3/20 0.39
CYP3A4 P08684 3/20 0.39
L3MBTL1 Q9Y468 2/20 0.39
CYP2C19 P33261 2/20 0.39
ALDH1A1 P00352 4/20 0.39
USP2 O75604 2/20 0.39
NPSR1 Q6W5P4 1/20 0.39
POLB P06746 2/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
NAMPT P43490 1/20 0.39
GAA P10253 1/20 0.38
PKM P14618 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
TSHR P16473 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5686577 1.00 MAPK1 (0.45) MAPK1IDO1ESR1ESR2MAPT
SCHEMBL4659905 1.00 MAPK1 (0.45) MAPK1IDO1ESR1ESR2MAPT
SCHEMBL4660100 1.00 MAPK1 (0.45) MAPK1IDO1ESR1ESR2MAPT
SCHEMBL5430666 0.93 MAPK1 (0.46) MAPK1IDO1ESR1ESR2MAPT
SCHEMBL5686369 0.90 ESR1 (0.44) ESR1ESR2L3MBTL1CYP2C19ALDH1A1
SCHEMBL4660129 0.90 ESR1 (0.44) ESR1ESR2L3MBTL1CYP2C19ALDH1A1
SCHEMBL4661405 0.89 MAPK1 (0.43) MAPK1IDO1ESR1ESR2MAPT
SCHEMBL4661527 0.89 ESR1 (0.41) MAPK1ESR1ESR2MAPTL3MBTL1
SCHEMBL4661523 0.89 ESR1 (0.41) MAPK1ESR1ESR2MAPTL3MBTL1
SCHEMBL4661570 0.88 MAPT (0.40) MAPK1IDO1MAPTCYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070299105-A1 2-Cyanopropanoic Acid Amide and Ester Derivatives and Methods of Their Use WYETH (US) 2007-12-27 US claimed
EP-1620102-B1 3-(1-NAPHTHYL)-2-CYANOPROPANOIC ACID DERIVATIVES AS ESTROGEN RECEPTOR LIGANDS WYETH CORP (US) 2008-12-24 EP disclosed
US-20070299105-A1 2-Cyanopropanoic Acid Amide and Ester Derivatives and Methods of Their Use WYETH (US) 2007-12-27 US disclosed
EP-1620102-A2 3-(1-NAPHTHYL)-2-CYANOPROPANOIC ACID DERIVATIVES AS ESTROGEN RECEPTOR LIGANDS Wyeth (US) 2006-02-01 EP disclosed
US-20050256132-A1 Use of ER selective NF-kB inhibitors for the treatment of sepsis WYETH (US) 2005-11-17 US disclosed
US-20050004164-A1 2-Cyanopropanoic acid amide and ester derivatives and methods of their use WYETH 2005-01-06 US disclosed
WO-2004099150-A2 3-(1-NAPHTHYL)-2-CYANOPROPANOIC ACID DERIVATIVES AS ESTROGEN RECEPTOR LIGANDS WYETH (US) 2004-11-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050256132-A1 Use of ER selective NF-kB inhibitors for the treatment of sepsis NFKBIA, IKBKB, NFKB2 MAPK1 445/4885IDO1 4559/4885ESR1 10/4885
US-20070299105-A1 2-Cyanopropanoic Acid Amide and Ester Derivatives and Methods of Their Use HCAR2, PCCA, MCCC2 MAPK1 1030/4885IDO1 1322/4885ESR1 4478/4885
US-20050004164-A1 2-Cyanopropanoic acid amide and ester derivatives and methods of their use HCAR2, PCCA, MCCC2 MAPK1 1112/4885IDO1 882/4885ESR1 4557/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.